Duong Kelvin, Aisenstat Maximilian, Chen John Z, Murphy Brynn, Tavernini Scott, Wang Hui, Reiz Béla, Zheng Jing, Whittal Randy, McClary Wynton D, Gerhardt Alana, Fox Christopher B, Finlay Warren H, Vehring Reinhard, Martin Andrew R
Department of Mechanical Engineering, University of Alberta, Edmonton, Canada.
Access to Advanced Health Institute (AAHI), Seattle, Washington, USA.
J Aerosol Med Pulm Drug Deliv. 2025 Feb;38(1):1-12. doi: 10.1089/jamp.2024.0029. Epub 2025 Jan 13.
Dry powders offer the potential to increase stability and reduce cold-chain requirements associated with the distribution of vaccines and other thermally sensitive products. The Alberta Idealized Nasal Inlet (AINI) is a representative geometry for characterization of nasal products that may prove useful in examining intranasal delivery of powders. Spray-dried trehalose powders were loaded at 10, 20, and 40 mg doses into active single-dose devices. Primary particle sizes (∼50 = 10 µm for powder A and 25 µm for powder B), and sizes dispersed by devices, were evaluated using laser diffraction. The interior of the AINI was coated with a glycerol-surfactant mixture to mitigate particle bounce, and flow rates of 7.5 or 15 L/min were drawn through the AINI. Deposition of trehalose powder was determined in the four regions of the AINI (vestibule, turbinates, olfactory, and nasopharynx), a downstream preseparator, and an absolute filter (representing lung deposition) using liquid chromatography coupled with mass spectrometry. Coating the AINI was effective in mitigating particle bounce for both trehalose powders. No difference in regional nasal deposition was observed when testing at a flow rate of 7.5 versus 15 L/min. A high fraction of both powders penetrated past the vestibule and deposited in the turbinates and nasopharynx for all loaded doses. For powder A, a non-negligible fraction of the recovered dose (up to 7%) is deposited on the filter, representing potential lung exposure. Conversely, a negligible fraction of the total recovered dose was deposited on the filter for powder B. Powders with a larger primary particle size showed reduced penetration through the nasal airways while maintaining high turbinate deposition. Optimized spray-dried powders offer the potential to target delivery to the peripheral nasal airways based on powder particle size while reducing lung exposure.
干粉剂有可能提高稳定性,并减少与疫苗及其他热敏产品分发相关的冷链需求。艾伯塔理想化鼻道入口(AINI)是用于表征鼻用产品的一种代表性几何结构,可能有助于研究粉末的鼻内给药情况。将喷雾干燥的海藻糖粉以10毫克、20毫克和40毫克的剂量装入单剂量活性装置中。使用激光衍射法评估了初级粒径(粉末A约为50±10微米,粉末B为25微米)以及装置分散后的粒径。AINI内部涂有甘油 - 表面活性剂混合物以减轻颗粒反弹,并以7.5或15升/分钟的流速通过AINI抽取气流。使用液相色谱 - 质谱联用技术,在AINI的四个区域(前庭、鼻甲、嗅觉区和鼻咽)、下游预分离器和绝对过滤器(代表肺部沉积)中测定海藻糖粉的沉积情况。对两种海藻糖粉而言,给AINI涂层都能有效减轻颗粒反弹。在7.5升/分钟与15升/分钟的流速下进行测试时,未观察到区域鼻腔沉积有差异。对于所有装载剂量,两种粉末中很大一部分都穿过前庭并沉积在鼻甲和鼻咽中。对于粉末A,回收剂量中不可忽略的一部分(高达7%)沉积在过滤器上,这代表有潜在的肺部暴露风险。相反,粉末B沉积在过滤器上的总回收剂量比例可忽略不计。初级粒径较大的粉末在保持高鼻甲沉积的同时,穿过鼻气道的渗透率降低。优化后的喷雾干燥粉末有可能根据粉末粒径将药物靶向递送至外周鼻气道,同时减少肺部暴露。